{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:23:37Z","timestamp":1772209417965,"version":"3.50.1"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0240102","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T13:51:41Z","timestamp":1601560301000},"page":"e0240102","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["J-shaped relationship between cardiovascular risk and efficacy of intensive blood pressure reduction: A post-hoc analysis of the SPRINT trial"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-4870","authenticated-orcid":true,"given":"Armin","family":"Attar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-7848","authenticated-orcid":true,"given":"Fatemeh","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5391-2490","authenticated-orcid":true,"given":"Roham","family":"Borazjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrab","family":"Sayadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"issue":"3","key":"pone.0240102.ref001","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11906-013-0340-9","article-title":"High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs","volume":"15","author":"S Bromfield","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"pone.0240102.ref002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"PA James","year":"2014","journal-title":"Jama"},{"issue":"9","key":"pone.0240102.ref003","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/2047487315613664","article-title":"Improving cardiovascular prevention in general practice: Results of a comprehensive personalized strategy in subjects at high risk","volume":"23","author":"F Avanzini","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"Suppl 2","key":"pone.0240102.ref004","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/heartjnl-2014-305693","article-title":"Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","year":"2014","journal-title":"Heart"},{"issue":"25 Suppl 2","key":"pone.0240102.ref005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"NJ Stone","year":"2014","journal-title":"Circulation"},{"issue":"19","key":"pone.0240102.ref006","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"PK Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"pone.0240102.ref007","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMp1716193","article-title":"Redefining Hypertension\u2014Assessing the New Blood-Pressure Guidelines","volume":"378","author":"G Bakris","year":"2018","journal-title":"N Engl J Med"},{"issue":"22","key":"pone.0240102.ref008","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A Randomized Trial of Intensive versus Standard Blood-Pressure Control","volume":"373","author":"JT Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0240102.ref009","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/2047487318800741","article-title":"Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial","volume":"26","author":"A Attar","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"pone.0240102.ref010","doi-asserted-by":"crossref","first-page":"e1002538","DOI":"10.1371\/journal.pmed.1002538","article-title":"Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data","volume":"15","author":"KN Karmali","year":"2018","journal-title":"PLoS Med"},{"issue":"19","key":"pone.0240102.ref011","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.jacc.2017.02.066","article-title":"Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment","volume":"69","author":"P Muntner","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"pone.0240102.ref012","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1161\/CIRCULATIONAHA.118.037669","article-title":"How Strong Is the Evidence to Support Blood Pressure Treatment Goal of 130\/80 mm\u2009Hg?","volume":"138","author":"S Kaul","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"pone.0240102.ref013","doi-asserted-by":"crossref","first-page":"e002126","DOI":"10.1161\/JAHA.115.002126","article-title":"Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels","volume":"4","author":"KN Karmali","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"pone.0240102.ref014","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jash.2013.12.006","article-title":"Effect of change in systolic blood pressure between clinic visits on estimated 10-year cardiovascular disease risk","volume":"8","author":"S Ye","year":"2014","journal-title":"J Am Soc Hypertens"},{"issue":"1","key":"pone.0240102.ref015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6963-3-13","article-title":"Physicians' ability to predict the risk of coronary heart disease","volume":"3","author":"M Pignone","year":"2003","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"pone.0240102.ref016","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jch.13720","article-title":"Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"21","author":"L Zhang","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"11","key":"pone.0240102.ref017","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1097\/HJH.0000000000001548","article-title":"Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure: overview and meta-analyses of randomized trials","volume":"35","author":"C Thomopoulos","year":"2017","journal-title":"J Hypertens"},{"issue":"15","key":"pone.0240102.ref018","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"S Yusuf","year":"2008","journal-title":"N Engl J Med"},{"issue":"9644","key":"pone.0240102.ref019","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"S Yusuf","year":"2008","journal-title":"Lancet"},{"issue":"10085","key":"pone.0240102.ref020","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(17)30754-7","article-title":"Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials","volume":"389","author":"M B\u00f6hm","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"pone.0240102.ref021","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1097\/HJH.0000000000001076","article-title":"Threshold for diagnosing hypertension by automated office blood pressure using random sample population data","volume":"34","author":"P Wohlfahrt","year":"2016","journal-title":"J Hypertens"},{"issue":"21","key":"pone.0240102.ref022","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease","volume":"374","author":"EM Lonn","year":"2016","journal-title":"N Engl J Med"},{"issue":"14","key":"pone.0240102.ref023","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1177\/2047487317723213","article-title":"SPRINT trial: It's not just the blood pressure!","volume":"24","author":"GF Berkelmans","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"19","key":"pone.0240102.ref024","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis","volume":"289","author":"BM Psaty","year":"2003","journal-title":"Jama"},{"issue":"1","key":"pone.0240102.ref025","first-page":"59","article-title":"Low Dose Spironolactone Monotherapy in the Management of Stage I Essential Hypertension: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial","volume":"34","author":"A Attar","year":"2018","journal-title":"Acta Cardiol Sin"},{"issue":"5","key":"pone.0240102.ref026","first-page":"328","article-title":"Effect of Chronic Kidney Disease on Cardiovascular Events: An Epidemiological Aspect from SPRINT Trial","volume":"13","author":"A Attar","year":"2019","journal-title":"Iran J Kidney Dis"},{"key":"pone.0240102.ref027","doi-asserted-by":"crossref","first-page":"2905167","DOI":"10.1155\/2020\/2905167","article-title":"Improved Landmark Dynamic Prediction Model to Assess Cardiovascular Disease Risk in On-Treatment Blood Pressure Patients: A Simulation Study and Post Hoc Analysis on SPRINT Data","volume":"2020","author":"M Sayadi","year":"2020","journal-title":"Biomed Res Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T13:51:59Z","timestamp":1601560319000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240102"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0240102","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738775206.793581347","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}